Mehnert J.M.Varga A.Brose M.S.Aggarwal R.R.CHIA-CHI LINPrawira A.De Braud F.Tamura K.Doi T.Piha-Paul S.A.Gilbert J.Saraf S.Thanigaimani P.Cheng J.D.Keam B.2022-09-152022-09-1520191471-2407https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062422113&doi=10.1186%2fs12885-019-5380-3&partnerID=40&md5=a5d47ca7873ab51133ece4af500a7fcdhttps://scholars.lib.ntu.edu.tw/handle/123456789/620258[SDGs]SDG3Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced, PD-L1-positive papillary or follicular thyroid cancerjournal article10.1186/s12885-019-5380-3308326062-s2.0-85062422113